Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer

Lung Cancer

Volumn 58, Issue 3, 2007, Pages 384-391

  Liu, Dage ^a   Nakano, Jun ^a   Ishikawa, Sinya ^a   Yokomise, Hiroyasu ^a   Ueno, Masaki ^a   Kadota, Kyuichi ^b   Urushihara, Masahide ^b   Huang, Cheng long ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Lung cancer; MMP 7; Prognosis; Proliferation; Squamous cell carcinoma; Wnt1

Indexed keywords

KI 67 ANTIGEN; MATRILYSIN; WNT1 PROTEIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 7; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; WNT1 PROTEIN;

EID: 35748985585     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.07.005     Document Type: Article

References (46)

1. Cersosimo R.J. Lung cancer: a review. Am J Health Syst Pharm 59 (2002) 611-642
2. Arriagada R., Bergman B., Dunant A., Le Chevalier T., Pignon J.P., and Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
3. Machtay M., Lee J.H., Stevenson J.P., Shrager J.B., Algazy K.M., Treat J., et al. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J Thorac Cardiovasc Surg 127 (2004) 108-113
4. Martin J., Ginsberg R.J., Venkatraman E.S., Bains M.S., Downey R.J., Korst R.J., et al. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol 20 (2002) 1989-1995
5. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
6. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3 (2002) 207-214
7. Overall C.M., and Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2 (2002) 657-672
8. Woessner Jr. J.F., and Taplin C.J. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem 263 (1988) 16918-16925
9. Miyazaki K., Hattori Y., Umenishi F., Yasumitsu H., and Umeda M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 50 (1990) 7758-7764
10. Wilson C.L., and Matrisian L.M. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28 (1996) 123-136
11. Mimori K., Yamashita K., Ohta M., Yoshinaga K., Ishikawa K., Ishii H., et al. Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells. Clin Cancer Res 10 (2004) 8243-8249
12. Yu W.H., Woessner Jr. J.F., McNeish J.D., and Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 16 (2002) 307-323
13. Powell W.C., Fingleton B., Wilson C.L., Boothby M., and Matrisian L.M. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr Biol 9 (1999) 1441-1447
14. Vargo-Gogola T., Crawford H.C., Fingleton B., and Matrisian L.M. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 408 (2002) 155-161
15. Davies G., Jiang W.G., and Mason M.D. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 7 (2001) 3289-3297
16. Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114 (2001) 111-118
17. Adachi Y., Yamamoto H., Itoh F., Hinoda Y., Okada Y., and Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45 (1999) 252-258
18. Zeng Z.S., Shu W.P., Cohen A.M., and Guillem J.G. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 8 (2002) 144-148
19. Honda M., Mori M., Ueo H., Sugimachi K., and Akiyoshi T. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 39 (1996) 444-448
20. Kitoh T., Yanai H., Saitoh Y., Nakamura Y., Matsubara Y., Kitoh H., et al. Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J Gastroenterol 39 (2004) 434-440
21. Yamamoto H., Adachi Y., Itoh F., Iku S., Matsuno K., Kusano M., et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59 (1999) 3313-3316
22. Yamashita K., Mori M., Shiraishi T., Shibuta K., and Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 6 (2000) 1169-1174
23. Jones L.E., Humphreys M.J., Campbell F., Neoptolemos J.P., and Boyd M.T. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 10 (2004) 2832-2845
24. Li Y.J., Wei Z.M., Meng Y.X., and Ji X.R. Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis. World J Gastroenterol 11 (2005) 2117-2123
25. Kawano N., Osawa H., Ito T., Nagashima Y., Hirahara F., Inayama Y., et al. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum Pathol 28 (1997) 613-622
26. Sasaki H., Yukiue H., Moiriyama S., Kobayashi Y., Nakashima Y., Kaji M., et al. Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J Surg Res 101 (2001) 242-247
27. Lin T.S., Chiou S.H., Wang L.S., Huang H.H., Chiang S.F., Shih A.Y., et al. Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer. Oncol Rep 12 (2004) 717-723
28. Brabletz T., Jung A., Dag S., Hlubek F., and Kirchner T. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155 (1999) 1033-1038
29. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Goss K.J., Rubinfeld B., Polakis P., et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18 (1999) 2883-2891
30. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
31. Sgonc R., and Wick G. Methods for the detection of apoptosis. Int Arch Allergy Immunol 105 (1994) 327-332
32. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L., and Matrisian L.M. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94 (1997) 1402-1407
33. Nagashima Y., Hasegawa S., Koshikawa N., Taki A., Ichikawa Y., Kitamura H., et al. Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors. Int J Cancer 72 (1997) 441-445
34. Huo N., Ichikawa Y., Kamiyama M., Ishikawa T., Hamaguchi Y., Hasegawa S., et al. MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 177 (2002) 95-100
35. Harrell P.C., McCawley L.J., Fingleton B., McIntyre J.O., and Matrisian L.M. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Exp Cell Res 303 (2005) 308-320
36. Viard-Leveugle I., Veyrenc S., French L.E., Brambilla C., and Brambilla E. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma. J Pathol 201 (2003) 268-277
37. Patterson B.C., and Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272 (1997) 28823-28825
38. Pozzi A., Moberg P.E., Miles L.A., Wagner S., Soloway P., and Gardner H.A. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci USA 97 (2000) 2202-2207
39. Ben-Ze'ev A., Shtutman M., and Zhurinsky J. The integration of cell adhesion with gene expression: the role of beta-catenin. Exp Cell Res 261 (2000) 75-82
40. Herzlinger D., Qiao J., Cohen D., Ramakrishna N., and Brown A.M. Induction of kidney epithelial morphogenesis by cells expressing Wnt-1. Dev Biol 166 (1994) 815-818
41. Dale T.C. Signal transduction by the Wnt family of ligands. Biochem J 329 (1998) 209-223
42. You Z., Saims D., Chen S., Zhang Z., Guttridge D.C., Guan K.L., et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 157 (2002) 429-440
43. Bienz M., and Clevers H. Linking colorectal cancer to Wnt signaling. Cell 103 (2000) 311-320
44. Ueda M., Gemmill R.M., West J., Winn R., Sugita M., Tanaka N., et al. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 85 (2001) 64-68
45. Ohgaki H., Kros J.M., Okamoto Y., Gaspert A., Huang H., and Kurrer M.O. APC mutations are infrequent but present in human lung cancer. Cancer Lett 207 (2004) 197-203
46. Huang C.L., Liu D., Nakano J., Ishikawa S., Kontani K., Yokomise H., et al. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer. J Clin Oncol 23 (2005) 8765-8773